Advertisement
Screener

Korro Bio, Inc. (KRRO) Material Contracts

Korro Bio, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-06: Form 10-Q; Exhibit 10.3; Description Consulting Agreement between Korro Bio, Inc. and Rachel Meyers.
  • 2026-08-06: Form 10-Q; Exhibit 10.2; Description Korro Bio, Inc. Amended and Restated Non-Employee Director Compensation Policy.
  • 2026-08-06: Form 10-Q; Exhibit 10.1; Description Korro Bio, Inc. 2026 Inducement Plan, and form of award agreements thereunder.
  • 2026-08-06: Form 8-K; Exhibit 10.1; Description Exchange Agreement, dated as of August 5, 2026, by and among the Korro Bio, Inc. and certain investors party thereto.
FiledFormExhibitDescription
2026-08-0610-Q10.3Consulting Agreement between Korro Bio, Inc. and Rachel Meyers
2026-08-0610-Q10.2Korro Bio, Inc. Amended and Restated Non-Employee Director Compensation Policy
2026-08-0610-Q10.1Korro Bio, Inc. 2026 Inducement Plan, and form of award agreements thereunder
2026-08-068-K10.1Exchange Agreement, dated as of August 5, 2026, by and among the Korro Bio, Inc. and certain investors party thereto
2026-03-098-K10.2Registration Rights Agreement, dated March 9, 2026, by and among Korro Bio, Inc. and the purchasers party thereto
2026-03-098-K10.1Subscription Agreement, dated March 9, 2026, by and among Korro Bio, Inc. and the purchasers party thereto
2025-12-188-K10.1Amended and Restated Employment Agreement with Jeffrey Cerio, dated effective December 15, 2025
2025-11-1210-Q10.3Separation Agreement and Release by and between Korro Bio, Inc. and Olukemi A. Olugemo, dated November 7, 2025
2025-11-1210-Q10.2First Amendment to Research Collaboration and License Agreement by and between Korro Bio, Inc. and Novo Nordisk A/S.
2025-10-088-K10.1Separation Agreement and Release by and between Korro Bio, Inc. and Vineet Agarwal, dated October 7, 2025.
2025-05-0710-Q10.1Employment Agreement, effective March 31, 2025 between Korro Bio, Inc. and Loïc Vincent.
2025-03-1810-K10.4Korro Bio, Inc. Amended and Restated Non-Employee Director Compensation Policy
2024-11-1210-Q10.4Employment Agreement, dated August 28, 2024 between Korro Bio, Inc. and Jeffrey Cerio.
2024-11-1210-Q10.3Consulting Agreement, dated August 26, 2024 between Korro Bio, Inc. and David Lucchino.
2024-11-1210-Q10.2Lease Agreement, dated April 25, 2022 between Korro Bio Ops, Inc. (formerly known as Korro Bio, Inc.) and NW Cambridge Property Owner LLC.
2024-11-1210-Q10.1Research Collaboration and License Agreement, dated September 13, 2024 between Korro Bio, Inc. and Novo Nordisk A/S.
2024-04-188-K10.2Registration Rights Agreement, dated April 17, 2024, by and among Korro Bio, Inc. and the purchasers party thereto
2024-04-188-K10.1Subscription Agreement, dated April 17, 2024, by and among Korro Bio, Inc. and the purchasers party thereto
2024-03-2610-K10.21Third Amendment to Lease Agreement, by and between Korro Bio, Inc. and ARE-MA Region No. 59, LLC, dated October 20, 2023.
2024-03-2610-K10.20Second Amendment to Lease Agreement, by and between Korro Bio, Inc. and ARE-MA Region No. 59, LLC, dated August 31, 2022.
2023-11-148-K10.2Employment Agreement, dated as of November 8, 2023, by and between Korro Bio, Inc. and Vineet Agarwal
2023-11-148-K10.1Employment Agreement, dated as of November 10, 2023, by and between Korro Bio, Inc. and Ram Aiyar, Ph.D.
2023-11-068-K10.13Warrant Agreement dated January 22, 2021
2023-11-068-K10.12Korro Bio, Inc. Senior Executive Cash Incentive Bonus Plan
2023-11-068-K10.11Korro Bio, Inc. Non-Employee Director Compensation Policy
2023-11-068-K10.10Korro Bio, Inc. 2023 Employee Stock Purchase Plan
2023-11-068-K10.9Korro Bio, Inc. 2023 Stock Option and Incentive Plan, and form of award agreements thereunder
2023-11-068-K10.8Korro Bio, Inc. 2019 Stock Incentive Plan, and form of award agreements thereunder
2023-11-068-K10.7Form of Indemnification Agreement for Directors of Korro Bio, Inc.
2023-11-068-K10.6Form of Indemnification Agreement for Officers of Korro Bio, Inc.
2023-11-068-K10.4Contingent Value Rights Agreement dated November 3, 2023.
2023-11-068-K10.3Form of Lock-Up Agreement.
2023-11-068-K10.2Registration Rights Agreement, dated July 14, 2023, by and among Korro Bio Ops, Inc. and certain parties thereto.
2023-11-068-K10.1Subscription Agreement, dated July 14, 2023, by and among Korro Bio Ops, Inc. and certain parties thereto.
2023-07-318-K10.1Separation Agreement, dated as of July 28, 2023, by and between Frequency Therapeutics, Inc. and Christopher Loose
2023-07-148-K10.5Form of CVR Agreement.
2023-07-148-K10.4Form of Lock-Up Agreement by and between Korro Bio, Inc. and directors and officers of Frequency Therapeutics, Inc.
2023-07-148-K10.3Form of Lock-Up Agreement by and between Korro Bio, Inc. and directors, officers and certain stockholders of Korro Bio, Inc.
2023-07-148-K10.2Form of Support Agreement by and between Korro Bio, Inc. and certain stockholders of Frequency Therapeutics, Inc.
2023-07-148-K10.1Form of Support Agreement by and between Frequency Therapeutics, Inc. and certain stockholders of Korro Bio, Inc.
2023-06-068-K10.1Amendment to Letter Agreement by and between Frequency Therapeutics, Inc. and Richard Mitrano, dated June 1, 2023
2023-05-1210-Q10.1Separation Agreement by and between Frequency Therapeutics, Inc. and Wendy Arnold, dated February 17, 2023
2023-03-298-K10.1Separation Agreement by and between Frequency Therapeutics, Inc. and Carl LeBel, dated March 23, 2023
2022-07-128-K10.1Sublease Agreement, dated July 8, 2022, by and between Frequency Therapeutics, Inc. and Saliogen Therapeutics, Inc.
2022-05-0410-Q10.2Employment Agreement, dated as of November 25, 2020, by and between Frequency Therapeutics, Inc. and Quentin McCubbin.
2022-04-158-K10.2Letter Agreement, dated April 15, 2022, by and between Frequency Therapeutics, Inc. and Wendy Arnold
2022-04-158-K10.1Letter Agreement, dated April 15, 2022, by and between Frequency Therapeutics, Inc. and Richard Mitrano
2022-03-318-K10.1Separation Agreement, dated as of March 31, 2022, by and between Frequency Therapeutics, Inc. and Peter P. Pfreundschuh
2022-03-1510-K10.7Exclusive Patent License Agreement, dated as of December 13, 2016, as amended, between Massachusetts Institute of Technology and Frequency Therapeutics, Inc.
2021-03-2910-K10.16Employment Agreement, effective February 3, 2020, by and between Frequency Therapeutics, Inc. and Wendy S. Arnold.
2020-12-168-K10.1Agreement for Termination of Lease and Voluntary Surrender of Premises, dated December 11, 2020, by and between Frequency Therapeutics, Inc. and ARE-MA-Region No. 20, LLC.
2020-12-158-K10.1Loan and Security Agreement, dated December 11, 2020, by and between Frequency Therapeutics, Inc. and Silicon Valley Bank.
2020-12-018-K10.1Employment Agreement, effective December 1, 2020, by and between Frequency Therapeutics, Inc. and Peter P. Pfreundschuh.
2020-07-218-K10.2Registration Rights Agreement, dated July 17, 2020, by and among Frequency Therapeutics, Inc. and the Investors named therein.
2020-07-218-K10.1Securities Purchase Agreement, dated July 17, 2020, by and among Frequency Therapeutics, Inc. and the Investors named therein.
2020-03-2610-K10.13Indenture of Lease, effective as of January 7, 2020 between HCP/KING 75 Hayden LLC and Frequency Therapeutics, Inc.
2020-03-2610-K10.5.1Lease Agreement, dated as of August 24, 2016, as amended, between ARE-MA Region No. 20 and Frequency Therapeutics, Inc.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Atrium Therapeutics, Inc. (RNA)United States$0.140B
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
Annexon, Inc. (ANNX)United States$0.147B-4.22
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
MEDICINOVA INC (MNOV)United States$0.130B-6.04
IMMUNIC, INC. (IMUX)United States$0.127B-1.88